Non-pharmacological Pain Care During Complex Wound Care Procedures
Launched by ACADEMISCH MEDISCH CENTRUM - UNIVERSITEIT VAN AMSTERDAM (AMC-UVA) · Feb 23, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
After inclusion and completion of the informed consent form, patients are randomly allocated to the intervention group or control group in a 1:1:1 ratio. Randomization will not be blinded since both the provider and patient know if the patient will be wearing the VR system or headphone with audio during wound care or not wearing the VR system or headphone with audio.
Patients are randomly assigned to one of three groups:
Group 1 - Intervention group 1, Virtual Reality Therapy Group 2 - Intervention group 2, Music Therapy Group 3 - Control group, care as usual
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals aged 18 or older who have wounds receiving wound care
- • Individuals who will undergo minimum of 1 to a maximum of 3 sequential complex wound care procedures before discharge
- • At least 1 prior painful wound care procedure, where they have indicated a VAS ≥ 4, or patients reporting a VAS ≥ 4 before initiating the wound care procedure.
- Exclusion Criteria:
- • Individuals not being able to understand Dutch language at primary school level
- • Individuals not being able to read or write Dutch
- • Individuals diagnosed with dementia and/or cognitive impairment
- • Individuals diagnosed with epilepsy
- • Individuals diagnosed with migraine
- • Individuals with severe dizziness and/or nausea
- • Individuals with a known history of claustrophobia
- • Individuals who are unable to sign informed consent owing to mental disorder or formally stated to be incompetent to decide
- • Individuals who have no feeling in the wound care area
- • Individuals with physical (and/or cognitive) disabilities on the face, eye, ear, nose and neck that prevent the use of the VR headgear and/or headphones
About Academisch Medisch Centrum Universiteit Van Amsterdam (Amc Uva)
The Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) is a leading academic medical center in the Netherlands, dedicated to advancing healthcare through innovative research, education, and patient care. Affiliated with the University of Amsterdam, AMC-UvA integrates clinical practice with cutting-edge biomedical research, fostering a multidisciplinary approach to medical challenges. The institution actively engages in clinical trials to enhance treatment options and improve patient outcomes, while promoting collaboration among healthcare professionals, researchers, and academic institutions globally. With a commitment to excellence and a focus on translational medicine, AMC-UvA plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amsterdam, Noord Holland, Netherlands
Patients applied
Trial Officials
Marlies Schijven, Prof. dr.
Principal Investigator
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials